Veeva Systems Inc. (NYSE:VEEV) SVP Sells $85,113.60 in Stock

Veeva Systems Inc. (NYSE:VEEV) SVP Frederic Lequient sold 320 shares of the business’s stock in a transaction on Monday, April 5th. The shares were sold at an average price of $265.98, for a total value of $85,113.60. Following the completion of the sale, the senior vice president now directly owns 862 shares in the company, valued at approximately $229,274.76. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Frederic Lequient also recently made the following trade(s):

  • On Friday, March 12th, Frederic Lequient sold 313 shares of Veeva Systems stock. The shares were sold at an average price of $256.66, for a total value of $80,334.58.

NYSE VEEV opened at $260.38 on Thursday. The stock has a 50-day simple moving average of $270.06 and a 200 day simple moving average of $279.14. The company has a market capitalization of $39.44 billion, a PE ratio of 121.67, a P/E/G ratio of 9.41 and a beta of 0.84. Veeva Systems Inc. has a 12 month low of $152.24 and a 12 month high of $325.54.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings data on Monday, March 1st. The technology company reported $0.78 EPS for the quarter, beating analysts’ consensus estimates of $0.68 by $0.10. Veeva Systems had a return on equity of 15.73% and a net margin of 24.88%. The business had revenue of $396.80 million during the quarter, compared to the consensus estimate of $380.20 million. During the same quarter in the prior year, the company posted $0.54 earnings per share. The firm’s revenue was up 27.4% on a year-over-year basis. On average, equities research analysts predict that Veeva Systems Inc. will post 1.95 EPS for the current year.

Institutional investors have recently made changes to their positions in the business. MUFG Americas Holdings Corp bought a new stake in shares of Veeva Systems in the fourth quarter worth about $26,000. Graves Light Private Wealth Management Inc. bought a new stake in shares of Veeva Systems in the fourth quarter worth about $27,000. Financial Avengers Inc. bought a new stake in shares of Veeva Systems in the fourth quarter worth about $27,000. RMR Wealth Builders bought a new stake in shares of Veeva Systems in the fourth quarter worth about $33,000. Finally, Capital Asset Advisory Services LLC bought a new stake in shares of Veeva Systems in the fourth quarter worth about $34,000. Institutional investors own 77.54% of the company’s stock.

VEEV has been the topic of several recent analyst reports. UBS Group raised Veeva Systems from a “sell” rating to a “neutral” rating and boosted their price target for the company from $245.00 to $250.00 in a research note on Wednesday, March 31st. Morgan Stanley boosted their price objective on Veeva Systems from $332.00 to $340.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 9th. SVB Leerink boosted their price objective on Veeva Systems from $282.00 to $294.00 and gave the stock a “market perform” rating in a research note on Tuesday, March 9th. DA Davidson boosted their price objective on Veeva Systems from $325.00 to $350.00 in a research note on Wednesday, March 3rd. Finally, KeyCorp boosted their price objective on Veeva Systems from $332.00 to $353.00 and gave the stock an “overweight” rating in a research note on Wednesday, February 17th. One research analyst has rated the stock with a sell rating, six have given a hold rating and fifteen have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $299.04.

Veeva Systems Company Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of multichannel customer relationship management applications, commercial data warehouse, allocation and alignment applications, master data management application, and data and services; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including medical, sales, and marketing, as well as research and development functions, such as clinical, regulatory, quality, and safety.

Further Reading: How is diluted EPS different from basic EPS?

Insider Buying and Selling by Quarter for Veeva Systems (NYSE:VEEV)

Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.